Literature DB >> 22219601

Predicting tumor response after preoperative chemoradiation using clinical parameters in rectal cancer.

Chan Ho Park1, Hee Cheol Kim, Yong Beom Cho, Seong Hyeon Yun, Woo Yong Lee, Young Suk Park, Doo Ho Choi, Ho-Kyung Chun.   

Abstract

AIM: To evaluate the clinical parameters and identify a better method of predicting pathological complete response (pCR).
METHODS: We enrolled 249 patients from a database of 544 consecutive rectal cancer patients who underwent surgical resection after preoperative chemoradiation therapy (PCRT). A retrospective review of morphological characteristics was then performed to collect data regarding rectal examination findings. A scoring model to predict pCR was then created. To validate the ability of the scoring model to predict complete regression.
RESULTS: Seventy patients (12.9%) achieved a pCR. A multivariate analysis found that pre-CRT movability (P = 0.024), post-CRT size (P = 0.018), post-CRT morphology (P = 0.023), and gross change (P = 0.009) were independent predictors of pCR. The accuracy of the scoring model was 76.8% for predicting pCR with the threshold set at 4.5. In the validation set, the accuracy was 86.7%.
CONCLUSION: Gross changes and morphological findings are important predictors of pathological response. Accordingly, PCRT response is best predicted by a combination of clinical, laboratory and metabolic information.

Entities:  

Keywords:  Downstaging; Preoperative chemoradiotherapy; Rectal cancer; Tumor regression; Validation

Mesh:

Year:  2011        PMID: 22219601      PMCID: PMC3247696          DOI: 10.3748/wjg.v17.i48.5310

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  29 in total

1.  Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer.

Authors:  E Kapiteijn; C A Marijnen; I D Nagtegaal; H Putter; W H Steup; T Wiggers; H J Rutten; L Pahlman; B Glimelius; J H van Krieken; J W Leer; C J van de Velde
Journal:  N Engl J Med       Date:  2001-08-30       Impact factor: 91.245

2.  Accuracy of transrectal ultrasound in predicting pathologic stage of rectal cancer before and after preoperative radiation therapy.

Authors:  J W Fleshman; R J Myerson; R D Fry; I J Kodner
Journal:  Dis Colon Rectum       Date:  1992-09       Impact factor: 4.585

3.  Preoperative versus postoperative chemoradiotherapy for rectal cancer.

Authors:  Rolf Sauer; Heinz Becker; Werner Hohenberger; Claus Rödel; Christian Wittekind; Rainer Fietkau; Peter Martus; Jörg Tschmelitsch; Eva Hager; Clemens F Hess; Johann-H Karstens; Torsten Liersch; Heinz Schmidberger; Rudolf Raab
Journal:  N Engl J Med       Date:  2004-10-21       Impact factor: 91.245

4.  A pathologic complete response to preoperative chemoradiation is associated with lower local recurrence and improved survival in rectal cancer patients treated by mesorectal excision.

Authors:  Julio García-Aguilar; Enrique Hernandez de Anda; Prayuth Sirivongs; Suk-Hwan Lee; Robert D Madoff; David A Rothenberger
Journal:  Dis Colon Rectum       Date:  2003-03       Impact factor: 4.585

5.  Accuracy of endoscopic ultrasound for restaging rectal cancer following neoadjuvant chemoradiation therapy.

Authors:  Arvydas Vanagunas; David E Lin; Steven J Stryker
Journal:  Am J Gastroenterol       Date:  2004-01       Impact factor: 10.864

6.  Operative versus nonoperative treatment for stage 0 distal rectal cancer following chemoradiation therapy: long-term results.

Authors:  Angelita Habr-Gama; Rodrigo Oliva Perez; Wladimir Nadalin; Jorge Sabbaga; Ulysses Ribeiro; Afonso Henrique Silva e Sousa; Fábio Guilherme Campos; Desidério Roberto Kiss; Joaquim Gama-Rodrigues
Journal:  Ann Surg       Date:  2004-10       Impact factor: 12.969

7.  T-level downstaging and complete pathologic response after preoperative chemoradiation for advanced rectal cancer result in decreased recurrence and improved disease-free survival.

Authors:  George Theodoropoulos; W E Wise; A Padmanabhan; B A Kerner; C W Taylor; P S Aguilar; K S Khanduja
Journal:  Dis Colon Rectum       Date:  2002-07       Impact factor: 4.585

8.  Postoperative adjuvant chemotherapy or BCG for colon cancer: results from NSABP protocol C-01.

Authors:  N Wolmark; B Fisher; H Rockette; C Redmond; D L Wickerham; E R Fisher; J Jones; A Glass; H Lerner; W Lawrence
Journal:  J Natl Cancer Inst       Date:  1988-03-02       Impact factor: 13.506

9.  Accuracy of MRI and 18F-FDG PET/CT for restaging after preoperative concurrent chemoradiotherapy for rectal cancer.

Authors:  Yong Beom Cho; Ho-Kyung Chun; Min Ju Kim; Joon Young Choi; Chi-Min Park; Byung-Tae Kim; Soon Jin Lee; Seong Hyeon Yun; Hee Cheol Kim; Woo Yong Lee
Journal:  World J Surg       Date:  2009-12       Impact factor: 3.352

10.  Phase II trial of preoperative 3D conformal radiotherapy, protracted venous infusion 5-fluorouracil, and weekly CPT-11, followed by surgery for ultrasound-staged T3 rectal cancer.

Authors:  Vivek K Mehta; Cheryl Cho; James M Ford; C Jambalos; Joseph Poen; Albert Koong; Albert Lin; J Augusto Bastidas; Harvey Young; Eamonn P Dunphy; George Fisher
Journal:  Int J Radiat Oncol Biol Phys       Date:  2003-01-01       Impact factor: 7.038

View more
  19 in total

1.  Intraoperative staging by surgeons in patients with rectal cancer after preoperative chemoradiation: diagnostic accuracy and prognostic value.

Authors:  Jung Wook Huh; Woo Yong Lee; Yoon Ah Park; Yong Beom Cho; Seong Hyeon Yun; Hee Cheol Kim; Ho-Kyung Chun
Journal:  J Cancer Res Clin Oncol       Date:  2014-04-06       Impact factor: 4.553

Review 2.  Clinical utility of pretreatment prediction of chemoradiotherapy response in rectal cancer: a review.

Authors:  Byong Chul Yoo; Seung-Gu Yeo
Journal:  EPMA J       Date:  2017-03-03       Impact factor: 6.543

3.  Chondrocyte Deformations Under Mild Dynamic Loading Conditions.

Authors:  Amin Komeili; Baaba Sekyiwaa Otoo; Ziad Abusara; Scott Sibole; Salvatore Federico; Walter Herzog
Journal:  Ann Biomed Eng       Date:  2020-09-21       Impact factor: 3.934

4.  Early dynamic transcriptomic changes during preoperative radiotherapy in patients with rectal cancer: a feasibility study.

Authors:  Stephane Supiot; Wilfried Gouraud; Loïc Campion; Pascal Jezéquel; Bruno Buecher; Josiane Charrier; Marie-Francoise Heymann; Marc-Andre Mahé; Emmanuel Rio; Michel Chérel
Journal:  World J Gastroenterol       Date:  2013-06-07       Impact factor: 5.742

5.  Clinical tumour size and nodal status predict pathologic complete response following neoadjuvant chemoradiotherapy for rectal cancer.

Authors:  Mikaela L Garland; Ryash Vather; Noah Bunkley; Maria Pearse; Ian P Bissett
Journal:  Int J Colorectal Dis       Date:  2014-01-14       Impact factor: 2.571

6.  Predictors of Pathologic Complete Response Following Neoadjuvant Chemoradiotherapy for Rectal Cancer.

Authors:  Eisar Al-Sukhni; Kristopher Attwood; David M Mattson; Emmanuel Gabriel; Steven J Nurkin
Journal:  Ann Surg Oncol       Date:  2015-12-14       Impact factor: 5.344

7.  Morphologic predictors of pathological complete response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer.

Authors:  Chongda Zhang; Feng Ye; Yuan Liu; Han Ouyang; Xinming Zhao; Hongmei Zhang
Journal:  Oncotarget       Date:  2017-12-19

8.  Immunohistochemical detection of p53 expression in patients with preoperative chemoradiation for rectal cancer: association with prognosis.

Authors:  Jung Wook Huh; Woo Yong Lee; Seok Hyung Kim; Yoon Ah Park; Yong Beom Cho; Seong Hyeon Yun; Hee Cheol Kim; Hee Chul Park; Doo Ho Choi; Joon Oh Park; Young Suk Park; Ho-Kyung Chun
Journal:  Yonsei Med J       Date:  2015-01       Impact factor: 2.759

9.  Future directions in combined modality therapy for rectal cancer: reevaluating the role of total mesorectal excision after chemoradiotherapy.

Authors:  Abhishek A Solanki; Daniel T Chang; Stanley L Liauw
Journal:  Onco Targets Ther       Date:  2013-08-14       Impact factor: 4.147

10.  Clinical parameters predicting pathologic complete response following neoadjuvant chemoradiotherapy for rectal cancer.

Authors:  Wei-Gen Zeng; Jian-Wei Liang; Zheng Wang; Xing-Mao Zhang; Jun-Jie Hu; Hui-Rong Hou; Hai-Tao Zhou; Zhi-Xiang Zhou
Journal:  Chin J Cancer       Date:  2015-08-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.